GleamWall
中文EN

TDOC Teladoc Health, Inc.

Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1477449 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.4%
TTM net income YoY30.8%
TTM EPS YoY31.7%
Revenue 3-yr CAGR-1.5%
Net income 3-yr CAGR—

Margins

Gross margin68.6%
Operating margin-6.6%
Net margin-6.3%
FCF margin10.6%
EBITDA margin—

Returns

ROE-11.5%
ROA-5.5%
ROIC (approx.)-23.2%
Asset turnover0.87x

Leverage & solvency

Liabilities / assets53.3%
Debt / equity0.00x
Current ratio0.87x
Interest coverage-8.00x

Cash quality & payout

Operating cash flow / net income-1.73x
Accruals ratio-15.0%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$605.10M$606.93M$613.85M$642.27M$626.44M$631.90M$629.37M$640.49M
Cost of revenue$190.26M$190.84M$197.53M$197.05M$187.18M$190.54M$196.83M$188.93M
Gross profit$414.84M$416.09M$416.32M$445.22M$439.26M$441.36M$432.54M$451.56M
R&D expense$65.55M$62.86M$67.86M$71.61M$67.57M$68.78M$69.96M$76.75M
SG&A expense$107.40M$104.03M$102.09M$108.42M$102.58M$108.11M$112.77M$100.00M
Operating income-$28.10M-$37.09M-$61.77M-$36.00M-$51.96M-$54.38M-$120.61M-$48.22M
Interest expense$4.93M$5.11M$5.37M$4.95M$4.53M$4.47M$5.76M$6.85M
Pretax income-$26.28M-$37.91M-$60.84M-$33.62M-$50.22M-$40.42M-$111.27M-$48.17M
Income tax$655,000$997,000$3.00M-$8.47M-$715,000-$7.76M-$18.25M$238,000
Net income-$26.93M-$38.91M-$63.84M-$25.14M-$49.51M-$32.66M-$93.01M-$48.41M
EPS (basic)-0.15-0.21-0.36—-0.28-0.19-0.53—
EPS (diluted)-0.15-0.21-0.36—-0.28-0.19-0.53—
Weighted avg. shares (diluted)181.88M181.03M179.12M—176.93M175.92M174.15M—
Balance sheet
Cash & equivalents$849.91M$774.35M$750.74M$781.08M$726.25M$679.62M$1.19B$1.30B
Receivables$230.95M$221.01M$213.63M$192.83M$210.76M$225.43M$232.97M$214.15M
Inventory$30.75M$28.82M$31.56M$38.20M$39.90M$38.16M$38.01M$38.14M
Current assets$1.23B$1.15B$1.13B$1.12B$1.09B$1.07B$1.60B$1.66B
PP&E, net$24.41M$24.69M$26.28M$26.97M$26.92M$27.67M$30.64M$29.49M
Goodwill$283.19M$283.19M$283.19M$283.19M$283.19M$283.19M$283.19M$283.19M
Intangibles$1.12B$1.18B$1.24B$1.30B$1.34B$1.38B$1.39B$1.43B
Total assets$2.78B$2.76B$2.81B$2.86B$2.88B$2.89B$3.44B$3.52B
Current liabilities$1.42B$1.38B$404.87M$404.74M$405.09M$401.77M$952.42M$941.53M
Total liabilities$1.48B$1.45B$1.47B$1.47B$1.49B$1.47B$2.02B$2.03B
Shareholders' equity$1.29B$1.31B$1.34B$1.39B$1.39B$1.42B$1.43B$1.49B
Shares outstanding182.25M181.65M180.43M178.32M177.35M176.61M175.34M173.41M
Cash flow statement
Operating cash flow$106.46M$64.66M$9.52M$87.74M$99.26M$91.43M$15.92M$85.90M
Capital expenditure$1.21M$928,000$1.66M$2.62M$2.28M$1.27M$2.73M$6.13M
Free cash flow$105.24M$63.73M$7.86M$85.12M$96.98M$90.16M$13.19M$79.77M
Investing cash flow-$30.82M-$41.59M-$36.52M-$34.32M-$48.72M-$59.70M-$123.27M-$29.64M
Financing cash flow$417,000$875,000-$2.45M$1.10M-$3.59M-$549.93M$769,000$2.06M
Stock-based compensation$11.62M$9.30M$14.61M$15.91M$17.00M$22.34M$25.16M$27.47M

Free plan shows the latest 8 periods; Pro shows all 50 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.